No Data
Gossamer Bio (GOSS) Receives a Buy From Piper Sandler
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
Express News | Gossamer Bio Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $9
Express News | Gossamer Bio Shares Are Trading Higher After Oppenheimer Initiated Coverage With an Outperform Rating and a Price Target of $9
Gossamer Bio Initiated at Outperform by Oppenheimer
loading...
loading...